Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02326272
Brief Title: A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO) (CIMPASI-2)

First Submitted : December 22, 2014
First Submitted that Met QC Criteria : December 22, 2014
First Posted : December 29, 2014 (Estimate)

Results First Submitted : June 22, 2018
Results First Submitted that Met QC Criteria : August 10, 2018
Results First Posted : August 13, 2018

Certification/Extension First Submitted : December 15, 2016
Certification/Extension First Submitted that Met QC Criteria : December 15, 2016
Certification/Extension First Posted : December 16, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : September 11, 2019
Last Update Posted : October 3, 2019